Patent Yard Sign in
Canadian application, no grantCanada

A method for combined parallel agent delivery and electroporation for cell structures and use thereof

CA 2468424 A1 · Owner: Nolkrantz, Kerstin · Inventors: Orwar, Owe; Farre, Cecilia; Karlsson, Mattias

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Disclosed is a method for parallel delivery of agents to and/or into a cell structure, wherein at least two electrolyte-filled tubes are provided together with a counter electrode, the tubes being connected to a voltage or current generator, said agents being introduced into the electrolyte solution contained in the tubes, which are placed close to the cell structure whereupon the agents are transported through the tubes to said cell structure and into the said structure through pores which have been formed by application of an electric field focused on the cell structure resulting in , electroporation of the cell structure. Also different applications of the method is disclosed, …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed November 27, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 27, 2022.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 27, 2024.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledNovember 27, 2002
GrantedNo grant recorded
Term endedNovember 27, 2022
Patent numberCA 2468424 A1
Classification (IPC)C12N13/00 +2 more

Timeline

Timeline From CIPO dates

2003200520072009201120132015201720192021Application filedNov 27, 2002Term endedNov 27, 2022

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.